Company intelligence / Profile preview

Galenova

Ownership: Private
Development stage: Other

Overview

Galenova is a commercial supplier offering active pharmaceutical ingredients (APIs), excipients, and intermediates for a broad range of therapeutic areas. The company provides bulk pharmaceutical products such as amitriptyline hydrochloride, baclofen, chloramphenicol succinate acid, clindamycin hydrochloride/phosphate, clobetasol propionate, clonidine, clotrimazole, cyclobenzaprine, dexamethasone/sodium phosphate and many others. No clinical trial results are reported as the company is not developing proprietary therapeutics but supplying ingredients.

Therapeutic areas: Other
Modalities: Small moleculeBiologic
Industry: Chemicals & Materials

Beyond the preview

Go deeper on Galenova.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Galenova.

Explore the full profile